CASI Pharmaceuticals, Inc. (CASI)

CASI Pharmaceuticals Statistics

Total Valuation

CASI has a market cap or net worth of $20.96 million. The enterprise value is $35.13 million.

Market Cap	20.96M
Enterprise Value	35.13M

Important Dates

The last earnings date was Friday, November 14, 2025, after market close.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

CASI has 20.55 million shares outstanding. The number of shares has increased by 19.10% in one year.

Current Share Class	20.55M
Shares Outstanding	20.55M
Shares Change (YoY)	+19.10%
Shares Change (QoQ)	+3.50%
Owned by Insiders (%)	10.86%
Owned by Institutions (%)	19.64%
Float	12.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.63
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.30

Current Ratio	0.30
Quick Ratio	0.19
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-47.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-61.80%
Return on Invested Capital (ROIC)	-234.29%
Return on Capital Employed (ROCE)	291.10%
Revenue Per Employee	$115,219
Profits Per Employee	-$211,953
Employee Count	233
Asset Turnover	0.61
Inventory Turnover	2.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.06% in the last 52 weeks. The beta is 0.82, so CASI's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-74.06%
50-Day Moving Average	1.52
200-Day Moving Average	1.83
Relative Strength Index (RSI)	28.01
Average Volume (20 Days)	23,290

Short Selling Information

The latest short interest is 122,597, so 0.60% of the outstanding shares have been sold short.

Short Interest	122,597
Short Previous Month	136,984
Short % of Shares Out	0.60%
Short % of Float	0.99%
Short Ratio (days to cover)	4.44

Income Statement

In the last 12 months, CASI had revenue of $26.85 million and -$49.39 million in losses. Loss per share was -$2.98.

Revenue	26.85M
Gross Profit	9.61M
Operating Income	-43.55M
Pretax Income	-49.39M
Net Income	-49.39M
EBITDA	-42.27M
EBIT	-43.55M
Loss Per Share	-$2.98

Balance Sheet

The company has $4.69 million in cash and $18.86 million in debt, giving a net cash position of -$14.17 million or -$0.69 per share.

Cash & Cash Equivalents	4.69M
Total Debt	18.86M
Net Cash	-14.17M
Net Cash Per Share	-$0.69
Equity (Book Value)	-28.59M
Book Value Per Share	-1.39
Working Capital	-27.51M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 35.80%, with operating and profit margins of -162.21% and -183.96%.

Gross Margin	35.80%
Operating Margin	-162.21%
Pretax Margin	-183.96%
Profit Margin	-183.96%
EBITDA Margin	-157.46%
EBIT Margin	-162.21%
FCF Margin	n/a

Dividends & Yields

CASI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.10%
Shareholder Yield	-19.10%
Earnings Yield	-235.62%
FCF Yield	n/a

Analyst Forecast

The average price target for CASI is $4.00, which is 288.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.00
Price Target Difference	288.35%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	-16.77%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 2, 2022. It was a reverse split with a ratio of 1:10.

Last Split Date	Jun 2, 2022
Split Type	Reverse
Split Ratio	1:10

Scores

CASI has an Altman Z-Score of -47.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-47.73
Piotroski F-Score	1